GMED Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
763.7M
-3.3%
789.6M
+3.9%
759.9M
-8.1%
826.4M
+7.5%
769.0M
Cost of Revenue
232.9M
-3.5%
241.4M
+3.1%
234.1M
-10.4%
261.1M
+3.4%
252.5M
Gross Profit
530.8M
-3.2%
548.2M
+4.3%
525.8M
-7.0%
565.3M
+9.4%
516.5M
Operating Expenses
353.3M
-3.4%
365.7M
-2.6%
375.4M
-5.2%
396.0M
+4.4%
379.2M
R&D
34.5M
-4.9%
36.3M
-0.5%
36.5M
+1.0%
36.2M
-5.0%
38.1M
SG&A
288.5M
+0.6%
286.8M
-3.7%
297.8M
-6.5%
318.5M
+1.6%
313.6M
Operating Income
177.6M
-2.7%
182.4M
+21.3%
150.4M
-11.2%
169.3M
+23.3%
137.4M
EBITDA
248.6M
-6.2%
265.0M
+14.3%
231.8M
-7.4%
250.3M
+10.9%
225.7M
Net Income
141.2M
-6.9%
151.6M
+21.9%
124.3M
-11.6%
140.6M
+18.2%
119.0M
EPS (Basic)
$1.05
-6.3%
$1.12
+21.7%
$0.92
-12.4%
$1.05
+19.3%
$0.88
EPS (Diluted)
$1.04
-5.5%
$1.10
+22.2%
$0.90
-12.6%
$1.03
+17.0%
$0.88
Shares (Diluted)
136.0M
-1.0%
137.4M
-0.6%
138.2M
+1.2%
136.6M
+0.9%
135.4M
GLOBUS MEDICAL (GMED) — Financials